Therapure Biopharma Inc. welcomes delegation from all three levels of government to its state-of-the-art facility
Mississauga, ON, May 6, 2016 - Therapure Biopharma Inc. (“Therapure”) today was delighted to host the Honourable Bill Morneau, Federal Minister of Finance; the Honourable Navdeep Bains, Federal Minister of Innovation, Science and Economic Development; Mayor Bonnie Crombie of Mississauga; MP Gagan Sikand; MP Iqra Khalid; MP Peter Fonseca; MP Sven Spengemann; MPP Bob Delaney; other government officials and distinguished guests at its state-of-the-art biologics manufacturing facility.
“We were delighted to host the delegation today, who recognized us as one of the country’s most successful growth companies in the innovation and manufacture of biologics. It was a great opportunity to demonstrate how the contribution under the Advanced Manufacturing Fund (AMF) is being used to develop our PlasmaCap&trade technology and scale-up to clinical manufacture of plasma proteins.” said Nick Green, President and CEO of Therapure.
PlasmaCap™ EBA technology yields more protein from the same amount of plasma, and separates the proteins faster, and at lower cost than existing processes used worldwide.
About Therapure Biopharma Inc.
Therapure is a biopharmaceutical company focused on manufacturing complex biologics for its customers and on developing, manufacturing and selling its own blood and plasma-related therapeutic products. Its passion for quality and patient safety underpins everything it does in its three divisions: Therapure Biomanufacturing, an award-winning contract development and manufacturing division; Therapure Biologics, a division focused on using its proprietary PlasmaCap EBA&trade technology to develop a portfolio of plasma-derived pharmaceutical products; and Therapure Innovations, a proprietary therapeutics and platform technologies research and development division. Therapure operates out of two facilities located in Mississauga: a 130,000 sq. ft. cGMP facility that includes biomanufacturing, research and quality control laboratories and is built to meet FDA (US), HPFB (Canada), EMA (Europe) and MHRA (UK) standards, and a new 43,000 sq. ft. facility housing 30,000 sq. ft. of cGMP warehouse.
Visit www.therapurebio.com for more information about Therapure Biopharma Inc. and its divisions.
For more information:
Director, Marketing and Special Projects